In a filing, Vir Biotechnology Inc revealed its Director SATO VICKI L unloaded Company’s shares for reported $0.11 million on Aug 01 ’25. In the deal valued at $4.99 per share,22,000 shares were sold. As a result of this transaction, SATO VICKI L now holds 1,276,391 shares worth roughly $6.52 million.
Then, Eisner Mark sold 6,796 shares, generating $37,162 in total proceeds. Upon selling the shares at $5.47, the EVP and Chief Medical Officer now owns 108,204 shares.
Before that, Eisner Mark sold 3,586 shares. Vir Biotechnology Inc shares valued at $19,629 were divested by the EVP and Chief Medical Officer at a price of $5.47 per share. As a result of the transaction, Eisner Mark now holds 104,618 shares, worth roughly $0.53 million.
JP Morgan downgraded its Vir Biotechnology Inc [VIR] rating to a Neutral from a an Overweight in a research note published on January 29, 2024; the price target was decreased to $9 from $23. A number of analysts have revised their coverage, including BofA Securities’s analysts, who decreased its forecast for the stock in early September from “a Buy” to “a Neutral”. JP Morgan also remained covering VIR and has increased its forecast on March 06, 2023 with a “an Overweight” recommendation from previously “Neutral” rating. Goldman revised its rating on February 21, 2023. It rated VIR as “a Buy” which previously was an “a Neutral”.
Price Performance Review of VIR
On Tuesday, Vir Biotechnology Inc [NASDAQ:VIR] saw its stock jump 0.20% to $5.11. Over the last five days, the stock has lost -2.67%. Vir Biotechnology Inc shares have fallen nearly -47.48% since the year began. Nevertheless, the stocks have fallen -30.38% over the past one year.
How much short interest is there in Vir Biotechnology Inc?
A steep rise in short interest was recorded in Vir Biotechnology Inc stocks on 2025-07-15, dropping by 73222.0 shares to a total of 11.29 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-13 was 11.37 million shares. There was a decline of -0.65%, which implies that there is a negative sentiment for the stock.
